Search for: "United States v. Rosati"
Results 1 - 20
of 41
Sorted by Relevance
|
Sort by Date
24 Jun 2014, 1:00 pm
On June 23, 2014, the United States Supreme Court issued its much-anticipated decision in Halliburton Co. v. [read post]
29 Apr 2011, 7:57 am
This summer, she goes to trial in United States v. [read post]
29 Aug 2016, 11:03 am
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
21 Apr 2009, 3:00 am
David O’Neil, Assistant to the Solicitor, will argue for 10 minutes for United States as amicus curiae supporting reversal. [read post]
6 Aug 2023, 10:00 pm
Professor Rosati thinks not. [read post]
12 Feb 2018, 6:27 am
No, says the European Court of Human Rights: Kat Eleonora Rosati discusses the recent European Court of Human Rights (ECtHR) decision in Sekmadienis v Lithuania, which clarifies the relationship between freedom of commercial expression and the vague notion of “public morals”. [read post]
13 Sep 2019, 6:17 am
The contested patents involve a compound patent owned by Gilead and a second medical use patent owned by the government of the United States. [read post]
15 Aug 2016, 7:05 am
Although it seemed that the audience was united in approval of the principle of that decision, there was plenty for discussion in the detail of precisely what was ordered, why, how and who was to pay for it.What is the role of EU law? [read post]
19 Aug 2016, 2:04 am
Ellie Wilson brings you the story.CJEU: "Flat-rate" reimbursement for legal fees must cover a significant part of the costs incurred by the successful party In Case C-57/15 United Video Properties, the CJEU held that while Article 14 Enforcement Directive does not prohibit flat-rate reimbursement of legal costs per se, it sets limits on how Member States can set the flat-rate. [read post]
11 May 2007, 6:10 am
KSR v. [read post]
28 Nov 2019, 10:39 am
| Feilin v. [read post]
7 Feb 2020, 1:41 pm
The court agreed with he EUIPO that the mark applied for was devoid of any distinctive character for all of the goods and services applied for.Eleonora Rosati reported on the eagerly awaited judgment of the CJEU in the Sky v Skykick case. [read post]
14 Nov 2019, 6:43 am
Our Permaket Eleonora Rosati was one of the speakers. [read post]
5 Sep 2016, 1:10 pm
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
15 Nov 2019, 6:17 am
Securities and Exchange Commission, on Wednesday, November 13, 2019 Tags: Capital markets, Institutional Investors, IPOs, Long-Term value, Private firms, Public firms, Retail investors 2020 Policy Guidelines—United States Posted by Courteney Keatinge and Kern McPherson, Glass, Lewis & Co., on Wednesday, November 13, 2019 Tags: Audit committee, Board performance, Boards of Directors, Compensation… [read post]
31 Aug 2018, 6:10 am
This was one of the United States’ stated objectives for NAFTA. [read post]
20 Sep 2016, 4:29 am
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
13 Apr 2011, 5:35 am
Attorney’s Office for the District of New Jersey April 6 charged a mergers and acquisitions attorney and a stock trader with conspiracy, securities fraud and other violations over their alleged roles in a long-running insider trading scheme that netted more than $32 million in illicit profits (United States v. [read post]
26 Mar 2018, 4:24 pm
Supreme Court unanimously held in Cyan, Inc. v. [read post]
10 Dec 2019, 12:20 am
GuestKat Peter Ling reports on this interesting decision.Richard Vary provides a guest contribution, in which he looks into the recent decision of the United States Court of Appeals of the Federal Circuit, which overturned a decision issued in December 2017 by Judge Selna in the Central District of California, instead going to a jury trial.Trade MarksGuestKat Léon Dijkman looks at the recent Opinion of Advocate General Bobek in Primart… [read post]
